BioScience Health Innovations Stock Price, News & Analysis
Company Description
BioScience Health Innovations (BHICD) is a publicly traded company.
On a trailing twelve-month basis, BioScience Health Innovations reported revenue of $1.8M with net income of $87K and diluted earnings per share of $0.00. The company operates at a net profit margin of 4.7%.
This page provides a comprehensive overview of BHICD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
SEC Filings
BioScience Health Innovations has filed 4 recent SEC filings, including 2 Form 8-K, 1 Form 10-K, 1 Form 10-Q. The most recent filing was submitted on April 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BHICD SEC filings →
Financial Highlights
BioScience Health Innovations generated $1.8M in revenue over the trailing twelve months, retaining a 70.9% gross margin, operating income reached $87K (4.7% operating margin), and net income was $87K, reflecting a 4.7% net profit margin. Diluted earnings per share stood at $0.00. The company generated $23K in operating cash flow.